Last $28.24 USD
Change Today +0.82 / 2.99%
Volume 537.1K
ANAC On Other Exchanges
Symbol
Exchange
NASDAQ GM
Berlin
As of 8:10 PM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for anacor pharmaceuticals inc (ANAC)

Year over year, Anacor Pharmaceuticals, Inc. has been able to grow revenues from $10.7M USD to $17.2M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 487.13% to 270.26%. This was a driver that led to a bottom line growth from a loss of $56.1M USD to a gain of $84.8M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Dec 31
2011
Dec 31
2012
Dec 31
2013
4 Year
Trend
Revenues27.820.310.717.2
TOTAL REVENUES27.820.310.717.2
Cost of Goods Sold29.956.152.346.6
GROSS PROFIT-2.0-35.8-41.6-29.3
Selling General & Admin Expenses, Total7.510.611.620.7
OTHER OPERATING EXPENSES, TOTAL7.510.611.620.7
OPERATING INCOME-9.5-46.3-53.2-50.0
Interest Expense-2.0-1.4-2.9-4.1
Interest and Investment Income0.00.10.10.1
NET INTEREST EXPENSE-2.0-1.2-2.8-4.0
Other Non-Operating Income (Expenses)1.40.0-0.1-0.7
EBT, EXCLUDING UNUSUAL ITEMS-10.1-47.6-56.1-54.6
Other Unusual Items, Total---0.3--141.1
Legal Settlements------142.5
Other Unusual Items---0.3---1.4
EBT, INCLUDING UNUSUAL ITEMS-10.1-47.9-56.186.5
Income Tax Expense------1.7
Earnings from Continuing Operations-10.1-47.9-56.184.8
NET INCOME-10.1-47.9-56.184.8
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-10.1-47.9-56.184.8
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-10.1-47.9-56.184.8
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ANAC:US $28.24 USD +0.82

ANAC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ANAC.
View Industry Companies
 

Industry Analysis

ANAC

Industry Average

Valuation ANAC Industry Range
Price/Earnings 17.1x
Price/Sales 59.9x
Price/Book 13.6x
Price/Cash Flow 16.9x
TEV/Sales 52.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANACOR PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.